netFormulary
 Report : A-Z HCD items in Formulary 27/09/2020 10:11:44
[Back]
 
Section Status CCG Name
13.05.03 Restricted Use CCG Certolizumab pegol ®
13.05 Restricted Use CCG Dupilumab Dupixent®
04.07.04.02 Formulary CCG Fremanezumab Ajovy®
13.05.03 Restricted Use CCG Risankizumab Skyrizi®
01.05 Restricted Use CCG Tofacitinib XELJANZ®
10.01.03 Restricted Use CCG Tofacitinib XELJANZ®
01.05 Restricted Use CCG Ustekinumab Stelara®
Leicestershire Health Community